Kolosis BIO Announces 2021 Results
Kolosis BIO, LLC (Kolosis), a pure-play orthobiologics company and an exclusive partner to MTF Biologics, announced today its 2021 results and 2022 expectations.
Menu
Kolosis BIO, LLC (Kolosis), a pure-play orthobiologics company and an exclusive partner to MTF Biologics, announced today its 2021 results and 2022 expectations.
Salt Lake City, Utah, – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the relocation of its global headquarters to the historic Seed Building in downtown Salt Lake City.
Kolosis BIO, a privately-held pure-play orthobiologics company, announces its support of the 2022 Montana Orthopedic Society meeting, January 14-16 at the Yellowstone Conference Center in Big Sky, Montana.
Salt Lake City, Utah – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the completion and release of a scientific white paper studying the effects of terminal sterilization on allograft tissues.
Salt Lake City, Utah. – Kolosis BIO, a privately-held pure-play orthobiologics company, announces its support of the 2021 Society of Military Orthopedic Surgeons, December 14-17 at the Resort at Squaw Creek in Olympic Valley, California.
Salt Lake City, Utah – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Maxwell Hunter as the company’s Chief Operating Officer.
Salt Lake City, Utah – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Keegan Begley as the company’s President.
SALT LAKE CITY, Utah–(BUSINESS WIRE)—Kolosis BIO, LLC (Kolosis) announced today, in collaboration with MTF Biologics (MTF), the market release of Kore Fiber™, an exclusively processed demineralized cortical fiber allograft for Kolosis.
